Low risk of primary clostridium difficile infection with tetracyclines: A systematic review and meta-analysis
Clinical Infectious Diseases | Sep 21, 2017
Tariq R, et al. - A systematic review and meta-analysis of studies was conducted to assess the risk of Clostridium difficile infection (CDI) with tetracyclines compared with the risk with other antibiotics. Findings suggested a decreased risk of CDI with tetracyclines administration in comparison to other antimicrobials. Whenever appropriate, it could be reasonable to use tetracyclines to decrease the burden of future CDI associated with antibiotic use.
Methods
- A systematic search was undertaken of MEDLINE, Embase, and Web of Science from January 1978 through December 2016 to include studies assessing the association between tetracycline use and risk of CDI.
- Researchers assessed the weighted summary estimates using generalized inverse variance with a random-effects model using RevMan 5.3.
- They assessed study quality using the Newcastle-Ottawa scale.
Results
- From 1993 to 2012, researchers included six studies (4 case-control, 2 cohort) with patient recruitment.
- Meta-analysis of these studies using the random-effects model suggested that tetracycline use was associated with a decreased risk of CDI (odds ratio, 0.62; 95% CI, 0.47Â0.81; P<.001).
- Significant heterogeneity was revealed among the studies, with an I2 of 53%.
- There appeared no publication bias.
- Subgroup analysis of studies evaluating the risk of CDI with doxycycline alone also indicated a decreased risk of CDI (odds ratio, 0.55; 95% CI, 0.40Â0.75; P<.001).
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries